136 related articles for article (PubMed ID: 32657879)
1. Head-to-Head Comparison of the Two MAO-B Radioligands, 18F-THK5351 and 11C-L-Deprenyl, to Visualize Astrogliosis in Patients With Neurological Disorders.
Ishibashi K; Kameyama M; Miura Y; Toyohara J; Ishii K
Clin Nucl Med; 2021 Jan; 46(1):e31-e33. PubMed ID: 32657879
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using
Ishibashi K; Miura Y; Hirata K; Toyohara J; Ishii K
BMC Med Imaging; 2020 Jul; 20(1):81. PubMed ID: 32664871
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase B inhibitor, selegiline, reduces
Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of MAO-B PET using
Ishibashi K
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():31-43. PubMed ID: 37973072
[TBL] [Abstract][Full Text] [Related]
5. 18F-THK5351 PET Can Identify Astrogliosis in Multiple Sclerosis Plaques.
Ishibashi K; Miura Y; Hirata K; Toyohara J; Ishii K
Clin Nucl Med; 2020 Feb; 45(2):e98-e100. PubMed ID: 31348091
[TBL] [Abstract][Full Text] [Related]
6. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
[TBL] [Abstract][Full Text] [Related]
7. First-in-Humans Evaluation of
Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bozinovski S; Huang K; Lopresti BJ; Yanai K; Rowe CC; Okamura N
J Nucl Med; 2022 Oct; 63(10):1551-1559. PubMed ID: 35086898
[TBL] [Abstract][Full Text] [Related]
8. Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.
Ishibashi K; Miura Y; Tago T; Toyohara J; Higashihara M; Iwata A; Ishii K
Clin Nucl Med; 2022 Jul; 47(7):e489-e495. PubMed ID: 35675140
[TBL] [Abstract][Full Text] [Related]
9. Correlations of
Harada R; Ishiki A; Kai H; Sato N; Furukawa K; Furumoto S; Tago T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Nakamura T; Yoshikawa T; Iwata R; Tashiro M; Sasano H; Kitamoto T; Yanai K; Arai H; Kudo Y; Okamura N
J Nucl Med; 2018 Apr; 59(4):671-674. PubMed ID: 28864633
[TBL] [Abstract][Full Text] [Related]
10. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET.
Johansson A; Engler H; Blomquist G; Scott B; Wall A; Aquilonius SM; Långström B; Askmark H
J Neurol Sci; 2007 Apr; 255(1-2):17-22. PubMed ID: 17346749
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of monoamine oxidase B in peripheral organs in humans.
Fowler JS; Logan J; Wang GJ; Volkow ND; Zhu W; Franceschi D; Pappas N; Ferrieri R; Shea C; Garza V; Xu Y; MacGregor RR; Schlyer D; Gatley SJ; Ding YS; Alexoff D
J Nucl Med; 2002 Oct; 43(10):1331-8. PubMed ID: 12368371
[TBL] [Abstract][Full Text] [Related]
12. Monoamine Oxidase B Binding of 18F-THK5351 to Visualize Glioblastoma and Associated Gliosis: An Autopsy-Confirmed Case.
Tago T; Toyohara J; Sengoku R; Murayama S; Ishii K
Clin Nucl Med; 2019 Jun; 44(6):507-509. PubMed ID: 30985435
[TBL] [Abstract][Full Text] [Related]
13. 18F-THK5351 PET Can Identify Lesions of Acute Traumatic Brain Injury.
Takami Y; Yamamoto Y; Norikane T; Mitamura K; Hatakeyama T; Nishiyama Y
Clin Nucl Med; 2020 Nov; 45(11):e491-e492. PubMed ID: 32657863
[TBL] [Abstract][Full Text] [Related]
14. Potential Use of 18F-THK5351 PET to Identify Wallerian Degeneration of the Pyramidal Tract Caused by Cerebral Infarction.
Ishibashi K; Kameyama M; Tago T; Toyohara J; Ishii K
Clin Nucl Med; 2017 Dec; 42(12):e523-e524. PubMed ID: 29076904
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging-pathological correlations of [
Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
[TBL] [Abstract][Full Text] [Related]
16. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154
[TBL] [Abstract][Full Text] [Related]
17. Clinical Application of 18F-THK5351 PET to Identify Inflammatory Lesions Through Imaging Astrogliosis in a Case of Cytomegalovirus Ventriculoencephalitis.
Hatano K; Ishibashi K; Yamada K; Ishii K; Iwata A
Clin Nucl Med; 2023 Oct; 48(10):e489-e490. PubMed ID: 37682617
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain.
Fowler JS; Wolf AP; MacGregor RR; Dewey SL; Logan J; Schlyer DJ; Langstrom B
J Neurochem; 1988 Nov; 51(5):1524-34. PubMed ID: 3139834
[TBL] [Abstract][Full Text] [Related]
19. Multitracer Approach to Understanding the Complexity of Reactive Astrogliosis in Alzheimer's Brains.
Fontana IC; Kumar A; Okamura N; Nordberg A
ACS Chem Neurosci; 2024 Jan; 15(2):328-336. PubMed ID: 38133820
[TBL] [Abstract][Full Text] [Related]
20. 18F-THK5351 PET Can Identify Core Lesions in Different Amyotrophic Lateral Sclerosis Phenotypes.
Higashihara M; Ishibashi K; Tokumaru AM; Iwata A; Ishii K
Clin Nucl Med; 2021 Dec; 46(12):e582-e583. PubMed ID: 34115705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
